Peptide Therapeutics Market Value to Triple Over 2020-2030Peptides therapeutics, over the past several decades, have emerged as a potential drug candidate, and is currently a bullish market, considering substantial drop in the availability of non-peptide chemical drugs. Initially, peptide therapeutics had applications limited to hormonal therapy and diagnostics, yet, with technological advances, they are broadly employed in treating chronic metabolic and oncological diseases. Over the decade ahead, the global value of the peptide therapeutics market will surge nearly thrice. Future prospects of market growth lie in characteristics such as targeted drug delivery, safety, and enhanced specificity.
Peptide Therapeutics Market: Key Insights
- The global peptide therapeutics market will cross US$ 70 Bn in 2029.
- Rise in cases of oncological disorders in tandem with increasing healthcare spending would be critical in shaping market growth.
- Application of peptide therapeutics would be prominent in cancer treatment; adoption in treating metabolic disorders to rise.
- Parenteral route continues to attract significant stakeholders’ attention; market players to shift away from transdermal route.
- North America would remain in the vanguard of peptide therapeutics market; Asia Pacific (APAC) to represent worthwhile prospects.
KEY FACTORS SHAPING PEPTIDE THERAPEUTICS MARKET
Rising Prevalence of Oncological Disorders
Cancer is among the leading reasons behind mortalities, globally. FMI finds that, around 10 million mortalities due to cancer and around 19 million new cases are registered worldwide each year. Chemotherapy - conventional method of treating cancer - carries the drawback of inaccurate drug delivery to the intended location. In addition, it affects the normal cells adjacent to the targeted location. Application of peptide therapeutics in cancer treatment holds great promise in shaping the future landscape of the peptide therapeutics market.
Tech-driven Advancements to Provide Impetus to Growth Engine
Tech-driven advancements have been beneficial in bringing down overall costs involved in the production of peptide therapeutics. This has influenced manufacturers and suppliers to unleash novel avenues of manufacturing peptide therapeutics as well as address prolonged and complex chains of peptides. Radical shift towards hybrid technologies in order to reduce the strain on resources is likely to propel the global peptide therapeutics market in the near term.
COVID-19 Pandemic to Hit Profit Margins of Manufacturers
The COVID-19 pandemic has been severely affecting the global economic order, and, in turn, overwhelming almost every industry, with the healthcare industry at the front line of the pandemic. As the epidemiological numbers continue to rise, governments around the world have imposed travel restrictions, self-quarantines, and social distancing norms. This will adversely affect businesses and consumer spending until Q2 ends. These factors will have a negative impact on the global peptide therapeutics market.
Peptide Therapeutics Market: Structure Analysis
- The global peptide therapeutics market is consolidated, with a limited number of players operating in the market landscape.
- Leading players are emphasizing on market expansion through distribution agreements, joint ventures, and exploring white spaces in the peptide therapeutics market.
- In addition, established players are collaborating with local players in a bid to improve their regional presence and expand their production capacities.
Market Value in 2019
US$ 25.6 Bn
Application, Route of Administration, Marketing, and Region
North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and the Middle East & Africa
AstraZeneca plc., Eli Lilly and Company, Merck & Co. Inc., Novo Nordisk A/S, and Teva Pharmaceutical Industries Ltd.
High Preference for Parenteral Route of Administration
Parenteral route enables enhanced bioavailability, swifter onset of action, and better clinical outcomes, and, as such, is a preferable mode for delivering peptide therapeutics. The subcutaneous drug delivery route captures over 70% of total market stack, and would maintain its positive trend in the coming years. However, parenteral route results in potential side effects and requires skilled staff for administration. Market players are thus moving to other administration routes, such as the oral route, which causes minimal pain and eliminates the need for external assistance.
Developed Regions to Represent Hub of Value-capture Opportunities
North America and Western Europe are characterized by conducive healthcare and payer infrastructure, and strong foothold of prominent healthcare industry executives. Together, these developed regions procure over 60% of overall peptide therapeutics market revenue. Moving forward, market players are also uncovering new revenue lines in Asia Pacific (APAC). Affordable raw material prices and expanding base of outsourcing service providers are bringing the region to the attention of stakeholders. Towards the end of the forecast period, the APAC peptide therapeutics market will hit the US$ 10 Bn mark.
Outsourcing to CMOs - Sound Strategy to Gain Competitive Edge
Contract manufacturing organizations (CMOs) that provide end-to-end services to biotech and pharmaceutical companies are capturing huge attention, as they deliver better manufacturing, and compliance experience. Players in the peptide therapeutics market are putting greater emphasis on outsourcing drug manufacturing to CMOs in order to curb operational expenses. Manufacturing peptide therapeutics provides limited room for players to develop distinctive strategies to secure a competitive edge. Pharmerging contract manufacturing allows market players to add technical resources to their existing business models.
Cancer treatment remains prominent application area
Metabolic disorders treatment to offer potential avenues
Parenteral route remains highly preferable
Transdermal route to witness gradual drop
Branded marketing to procure leading value share
Generic marketing to exhibit stellar CAGR
How Growth will Unfold
Cancer is among the leading reasons for premature mortalities in a majority of countries. FMI finds that, in the following two decades, the number of new cancer cases is expected to cross 27 million per year, globally. These facts and figures are enabling broader application of peptide therapeutics for the treatment of oncological disorders, wherein, their application would generate greater total returns to shareholders. Moreover, peptide therapeutics are finding increasing scope of application in treating metabolic and central nervous system (CNS) disorders.
* This data is only a representation. Actual data may vary and will be available in report.Click Here To Know How The Growth Will Unfold
Custom Market Research Services
FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.
A recent market study published by Future Market Insights (FMI) offers global industry analysis of 2015-2019 and forecasts for 2020-2030. The study also offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical as well as current growth parameters of the peptide therapeutics market, growth prospects of the market are obtained with maximum precision.
Peptide Therapeutics Market Taxonomy
The global peptide therapeutics market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the readers.
- Cardiovascular Diseases
- Central Nervous Systems
- Metabolic Disorders
- Hematological Disorders
- Gastrointestinal Disorders
- Respiratory Disorders
- Other Applications
Route of Administration
- Parenteral Route
- Mucosal Route
- Oral Route
- Transdermal Route
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific Excluding Japan
The report commences with the executive summary of the peptide therapeutics market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the peptide therapeutics market.
Readers can find the detailed segmentation and the definition of the peptide therapeutics market in this chapter, which will help them understand the basic information about the peptide therapeutics market. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the peptide therapeutics market report.
The peptide therapeutics market report provides the key market trends that are expected to significantly impact the market growth during the forecast period. Detailed industry trends are provided in this section.
This chapter explains the key macroeconomic factors that are expected to influence the growth of the peptide therapeutics market during the forecast period. Along with the macroeconomic factors, this section also highlights the impact factors, supply chain, forecast factors, Porter’s five forces analysis, and value chain analysis for the peptide therapeutics market. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section. Moreover, readers will understand the key trends followed by the leading manufacturers in the peptide therapeutics market.
This section includes the factors that have emerged as key successful factors and the strategies adopted by key market participants. Additional viewpoint on global average pricing analysis benchmark, consumer sentiment analysis, and value chain analysis, which are likely to contribute to market growth.
This section explains the global market value analysis and forecast for the peptide therapeutics market between the forecast periods of 2020-2030. This chapter includes a detailed analysis of the historical peptide therapeutics market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2020), and an incremental $ opportunity for the forecast period (2020-2030). This section also explains the global market volume analysis and forecast for the peptide therapeutics market during the forecast period.
Based on application, the peptide therapeutics market is segmented into cancer, cardiovascular diseases, central nervous systems, metabolic disorders, infection, hematological disorders, gastrointestinal disorders, dermatology, respiratory disorders, acromegaly, and other applications. Readers can find information about the key trends and developments in the peptide therapeutics market and market attractiveness analysis based on application.
Based on route of administration, the peptide therapeutics market is segmented into parenteral route, mucosal route, oral route, and transdermal route. In this chapter, readers can find information about the key trends and developments in the peptide therapeutics market and market attractiveness analysis based on route of administration of peptide therapeutics.
Based on marketing, the peptide therapeutics market is segmented into branded and generic. In this chapter, readers can find information about the key trends and developments in the peptide therapeutics market and market attractiveness analysis based on the marketing of peptide therapeutics.
This chapter explains how the peptide therapeutics market will grow across various geographic regions, such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Japan, and the Middle East & Africa (MEA).
This chapter includes a detailed analysis of the growth of the North America, along with a country-wise assessment that includes the U.S. and Canada.
Readers can find detailed information about several factors such as the pricing analysis, which are impacting growth of the Latin America peptide therapeutics market. This chapter also includes the growth prospects of the peptide therapeutics market in the leading Latin America countries such as Brazil, Mexico, and the Rest of Latin America.
Important growth prospects of the peptide therapeutics market based on its end users in several countries such as Germany, the UK, France, Spain, Italy, and the Rest of Western Europe, are included in this chapter.
Poland, and Russia are among the leading countries in the Eastern Europe region, which are the prime subjects of assessment to obtain the growth prospects of the Eastern Europe peptide therapeutics market in this chapter. Readers can find detailed information about the growth parameters of the Eastern Europe Peptide therapeutics market during the period 2020-2030.
This chapter highlights the growth of the peptide therapeutics market in East Asia by focusing on China, India, and Oceania. This section also helps readers understand the key factors that are responsible for the growth of the peptide therapeutics market in APEJ.
Japan is the prime subjects of assessment to obtain the growth prospects of the Japan peptide therapeutics market.
This chapter provides information about how the peptide therapeutics market will grow in the major countries in the MEA region such as GCC Countries, South Africa, Israel, and the rest of MEA, during the forecast period.
In this chapter, readers can find detailed information about the tier analysis and market concentration of the key players in the peptide therapeutics market, along with their market presence analysis by region and product portfolio.
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the peptide therapeutics market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are AstraZeneca plc., Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Lt. and others.
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the peptide therapeutics market report.
This chapter helps readers understand the research methodology followed to obtain the various conclusions as well as important qualitative and quantitative information about the peptide therapeutics market.
How the research was conducted?
- C - Level Executives
- Marketing Directors
- Sales Heads
- Portfolio Managers
- Purchasing Managers
- Medical Officers
- Device Development Heads
- Strategy Advisors
- R&D Managers
- Product Manufacturers
- Component Suppliers / OEMs
- Purchasing Departments
- Physicians / Nursing Managers
- Industry Experts
- Current Market Dynamics and Challenges
- Market Characteristics
- Market Performance and Growth Quadrants
- Competition Structure and Market Structure
- Strategic Growth Initiatives
- Product Adoption, utilization rate, substitutes
- Regulatory Landscape
- Products in Pipeline and Clinical Development
- Near-term and Long-term Market Growth Prospects
- Market Segment Splits and Authenticity
- Opinions on Market Projections and Validity of Assumptions
- Industry Magazines
- Organisation for Economic Co-operation and Development
- Emergency Care Research Institute
- Global Clinical research Organizations
- Research organisations
- Company Press Releases
- Annual Reports and Investor Presentations
- Peer-reviewed Journals
- Government Websites and Publications
- Trade Websites
- Clinical Trial Registries
- Country-specific Regulatory Authorities
- World Bank, WHO,
Primary Interview Splits